What do drug monopolies cost consumers in developing countries?

Abstract: This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Keywords: intellectual property rights; international price discrimination; TRIPS agreement; pharmaceutical industry; markups;

JEL Classification: D4; F13; L1; L65; O34;

Access Documents


Bibliographic Information

Provider: Federal Reserve Bank of New York

Part of Series: Staff Reports

Publication Date: 2011-12-01

Number: 530

Note: For a published version of this report, see Rebecca Hellerstein, "What Do Drug Monopolies Cost Consumers in Developing Countries?" Economics Letters 116, no. 1 (July 2012): 108-111.